2024. THE UTILIZATION OF DIOSGENIN FOR MANAGING THE GENETICALLY TRANSMITTED OPTIC NERVE SHEATH MENINGIOMAS (ONSMS). Journal of Research Administration. 6, 1 (Feb. 2024).